Latest Sign Lives of America’s Billionaires Are Completely Divorced from Their Nation’s Pandemic Misery WASHINGTON, D.C. – Futurist billionaire Elon Musk’s personal fortune blasted up faster than one of his rockets over the past 24 hours, going from $68 billion yesterday to $73 billion today—a breathtaking gain of $5 billion, according to Forbes’ real-time data […]
October 9, 2018
The 2018 Tax Debate Media Briefing Book
READ FULL REPORT HERE In Congress, Rep. Rod Blum (R-IA) is an original cosponsor of a resolution declaring the national debt “a threat to national security.” On her website, Rep. Mimi Walters (R-CA) says, “Our national debt is not only a threat to our financial security it is also a threat to our national security.” On his website, Rep. Erik […]
September 20, 2018
ANALYSIS OF TAX ISSUES IN THE 2018 FEDERAL MIDTERM ELECTIONS
KEY FINDINGS “Republicans lost the messaging battle on the [tax] issue, per a Sept. 2 polling memo prepared for the Republican National Committee. Their poll found that by 61% to 30%, voters said the law benefits “large corporations and rich Americans” over “middle class families.” The memo attributed this to message discipline from the tax […]
September 14, 2018
NO EVIDENCE TRUMP-GOP TAX CUTS ARE IMPROVING THE ECONOMY
Eight months since the tax cuts were passed in December 2017, here’s what the data show: Corporate profits up, corporate tax revenues down (Figure 1): In the second quarter of 2018 (six months after the tax cuts passed in December 2017), corporate after-tax profits were 16% higher than a year earlier in the second quarter […]
December 7, 2017
The Pharma Big 10: Price Gougers, Tax Dodgers
View the Full Report in PDF here. TOPLINES The report examines the profits, taxes, and drug prices of the 10 biggest U.S. pharmaceutical companies, the “Pharma Big 10”: Johnson & Johnson, Pfizer, Merck & Co., Gilead Sciences, AbbVie, Amgen, Eli Lilly & Co., Bristol-Myers Squibb, Biogen and Celgene. Between 2011 and 2015, the Pharma Big 10 […]